At a glance
ClinicalIndex Comparison RecordPhase 3Completed· 1,005 enrolled
Drug / intervention
low-LET photon therapyradiation
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
PHASE III STUDY OF POST-OPERATIVE EXTERNAL RADIOTHERAPY IN PATHOLOGICAL STAGE T3 N0 PROSTATIC CARCINOMA
European Organisation for Research and Treatment of Cancer - EORTC·interventional·Posted Jan 27, 2003·Updated Oct 16, 2012
In Brief
A Phase 3 clinical trial evaluating low-LET photon therapy for Prostate Cancer. Completed, enrolled 1,005 participants across 1 site.
Detailed Summary
RATIONALE: Radiation therapy uses high-energy x-rays to damage tumor cells and may be an effective treatment for prostate cancer. PURPOSE: Randomized phase III trial to compare radiation therapy with no further treatment in treating patients with stage III prostate cancer following radical prostatectomy.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsProstate Cancer
CountriesBelgium
Collaborators--
Timeline
Phase 3CompletedFinished
199219931994199519961997199819992000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
Enrollment StartDec 1992
Primary CompletionDec 2001
First PostedJan 2003
TodayJul 2026
First PostedJan 27, 2003
Enrollment StartDec 1, 1992
Primary CompletionDec 1, 2001
TodayJul 2, 2026
Enrollment to primary: 9 yearsPosted 23.4 years ago
Interventions
low-LET photon therapyradiation